Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81
Document › Details

ELRIG (UK) Ltd.. (9/23/20). "Press Release: ELRIG UK Elects Melanie Leveridge to Lead the Organisation as Chair". York.

Region Region United Kingdom (GB)
Organisations Organisation ELRIG (UK) Ltd.
  Group LRIG (Laboratory Robotics Interest Group)
  Organisation 2 GlaxoSmithKline plc (LSE: GSK, NYSE: GSK)
  Group GlaxoSmithKline (GSK) (Group)
Products Product laboratory equipment and instruments
  Product 2 drug screening (HTS)
Persons Person Leveridge, Melanie (ELRIG UK 202009– Chair main org GSK Head of Screening UK joined 2005)
  Person 2 Odgaard, Katie (Zyme Communications 201108 Senior Account Manager before College Hill Life Sciences)
     


> Drug discovery expert leads not-for-profit organisation to drive further collaboration between academia and biopharma industry

> Melanie to chair ELRIG Drug Discovery Digital 2020 from 6–16 October


The European Laboratory Research & Innovation Group (ELRIG) UK, today announced the election of Melanie Leveridge as Chair. Melanie will guide the not-for-profit organisation serving the life science and drug discovery communities, to help drive further collaboration and knowledge exchange between academic and biopharma industry thought-leaders, through the provision of scientific meetings and conferences on an open access basis. Melanie succeeds Steve Rees, who will be stepping down after four years as ELRIG Chair.

Melanie has 15 years’ experience in drug discovery, laboratory automation, screening and sample management and has been an active member of ELRIG since 2017, where she has played a key role as Chair of the Science Strategy Workgroup, and as a member of the Board of Directors with overall accountability for the scientific content of the organisation’s meetings.

Melanie is also Head of Screening, Profiling and Mechanistic Biology UK, and Global Compound Management at GlaxoSmithKline (GSK). Since joining GSK in 2005, she has held roles of increasing responsibility in a variety of small molecule discovery platform groups, leading teams to deliver high-throughput screening, lead optimisation profiling, assay development and mechanistic biology studies. Melanie has led numerous technology and capability development collaborations, particularly in the application of high-throughput mass spectrometry techniques for screening and compound profiling, a topic on which she has published a number of peer-reviewed articles. In her current role Melanie leads UK Assay Development and Compound Profiling capabilities, as well as the global Compound Management teams. 

Melanie’s first role as Chair will be to host ELRIG Drug Discovery Digital. The organisation’s first fully virtual conference includes a leading scientific programme of speakers, access to the latest technology breakthroughs, Early Career Professional development activities and the opportunity to connect and network with a diverse audience from across industry and academia.

Steve Rees, Former Chair of ELRIG UK and VP of Discovery Biology at AstraZeneca, said: “We are delighted to announce the election of Melanie as Chair. ELRIG has a critical role to play in creating the opportunity for scientists working in preclinical drug discovery in academia, the vendor community, contract research organisations, and large and small drug discovery organisations, to present their science, to network with peers and to establish new collaborations. Melanie brings a wealth of experience in drug discovery, laboratory automation, screening and sample management and I look forward to watching ELRIG grow under her leadership in the years to come.”

Melanie Leveridge, Chair of ELRIG UK and Head of Screening, Profiling and Mechanistic Biology at GlaxoSmithKline, said: “I am delighted and honoured to be taking up the position of ELRIG Chair. Now more than ever it is important that we keep connected as a scientific community, and ELRIG events provide the perfect mechanism for us to do that.

I would like to thank Steve for his exceptional leadership of ELRIG over the past four years. Under his guidance the organisation has gone from strength to strength, including an impressive series of successful events, networking opportunities, Early Career Professional programme and a strategic partnership with the British Pharmacological Society. The UK leads in biomedical science and ELRIG can be proud of the work that we do to support and sustain this community of scientists.

I am incredibly excited about ELRIG Drug Discovery Digital, which has everything you would expect from an ELRIG meeting with the added flexibility of tracks spread across eight days so you can choose the topics of most interest to you, without any conflicts.”

For further information about ELRIG’s team, please visit: https://elrig.org/the-elrig-team/

To find out more about ELRIG Drug Discovery Digital taking place from 6–16 October 2020, please visit: https://elrig.org/portfolio/drug-discovery-digital/


ENDS


Note to Editors:


ELRIG UK

Sanj Kumar
Tel: +44 7860 89 29 44
Email: sanj.kumar@elrig.org

Zyme Communications
Katie Odgaard / Michelle Ricketts
Tel: +44 (0)7787 502 947 / +44 (0)7789 053885
Email: katie.odgaard@zymecommunications.com / michelle.ricketts@zymecommunications.com


About ELRIG UK www.elrig.org

ELRIG UK is a not-for-profit organisation, based in the UK. We are leaders in the provision of scientific meetings and conferences; bringing together academic and biopharma industry experts and thought leaders to exchange ideas and information. Our primary objective is to provide outstanding, leading edge knowledge to the life sciences community on an open access basis.

With more than 7,000 life science professionals across the UK and Europe, our members include scientists, researchers, engineers, developers and business-people within academia, industry, government organisations and private institutes. 

Follow ELRIG UK on LinkedIn at ELRIG UK, and on Twitter @ELRIG_UK

   
Record changed: 2020-10-01

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for LRIG (Laboratory Robotics Interest Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] No Content Marketing 650x80px




» top